宫颈高级别鳞状上皮内病变锥切术后高危型 HPV 持续感染的研究进展
摘要
风险因素并探讨临床管理策略。方法：系统性检索与归纳国内外相关研究文献。结果：术后高危型人乳头瘤病毒持续感染
是导致患者病变残留、复发乃至进展为宫颈癌的核心风险预测指标。其主要风险因素可归纳为宿主因素、病毒因素、手术
相关因素以及术后干预措施四大方面。结论：临床管理应立足于多维度风险因素的全面评估，推行基于风险分层的个体化
随访方案，并积极倡导术后接种人乳头瘤病毒疫苗，此为降低复发风险的关键所在。
关键词
全文:
PDF镜像
|参考
[1]Santesso N, et al. Systematic reviews and meta-analysis
of benefits and harms of cryotherapy, LEEP, and cold knife
conization to treat cervical intraepithelial neoplasia. Int J Gynaecol
Obstet. 2016;132(3):266-71.
[2]Kalliala I, et al. Incidence and mortality from cervical
cancer and other malignancies after treatment of cervical
intraepithelial neoplasia: a systematic review and meta-analysis of
the literature. Ann Oncol. 2020;31(2):213-27.
[3] 张晶， 王丹波 . 子宫颈锥切术后高危型人乳头瘤病
毒阳性者规范化管理的专家共识 . 中国实用妇科与产科杂志 .
2021;37(06):650-3.
[4]Iida Y, et al. Prognostic Value of Human Papillomavirus
Genotyping before and after Cervical Conization for Squamous
Intraepithelial Lesion. Acta Cytol. 2023;67(1):17-26.
[5]Kang WD, et al. Significance of human papillomavirus
genotyping with high-grade cervical intraepithelial neoplasia
treated by a loop electrosurgical excision procedure. Am J Obstet
Gynecol. 2010;203(1):72.e1-6.
[6]Zhang G, et al. High-risk human papillomavirus infection
clearance following conization among patients with cervical
intraepithelial neoplasm grade 3 aged at least 45 years. Int J
Gynaecol Obstet. 2017;136(1):47-52.
[7]National Comprehensive Cancer Network. NCCN Clinical
Practice Guidelines in Oncology: Cervical Cancer Version 3.2023.
[8]Caselli E, et al. Vaginal microbiota and cytokine
microenvironment in HPV clearance/persistence in women
surgically treated for cervical intraepithelial neoplasia: An
observational prospective study. Front Cell Infect Microbiol.
2020;10:540900.
[9]Hoffman SR, et al. Patterns of persistent HPV infection
after treatment for cervical intraepithelial neoplasia (CIN): A
systematic review. Int J Cancer. 2017;141(1):8-23.
[10]Liang L, et al. Vaginal microbiota changes of persistent
human papillomavirus infection after cervical conization. Front
Cell Infect Microbiol. 2025;15:1544794.
[11] 陶佳， 等 . 高级别宫颈上皮内瘤变患者阴道微生
态对 HPV 感染转归的影响因素分析 . 中华医院感染学杂志 .
2020;30(4):581-5.
[12]Reuschenbach M, et al. Treatment characteristics, HPV
genotype distribution and risk of subsequent disease among women
with high-grade cervical intraepithelial neoplasia in Europe: A
systematic literature review. Eur J Obstet Gynecol Reprod Biol.
2024;300:129-40.
[13]Zhang Y, et al. Persistent HPV infection after ionization
of cervical intraepithelial neoplasia--a systematic review and
meta-analysis. BMC Womens Health. 2023;23(1):216.
[14]Cassani C, et al. The role of multiple high-risk human
papillomavirus infection on the persistence recurrence of high-
grade cervical lesions after standard treatment: A systematic
review and a meta-analysis. Acta Obstet Gynecol Scand.
2024;103(6):1028-35.
[15]Perkins RB, et al. 2019 ASCCP Risk-Based
Management Consensus Guidelines for Abnormal Cervical Cancer
Screening Tests and Cancer Precursors. J Low Genit Tract Dis.
2020;24(2):102-31.
[16]Arbyn M, et al. Incomplete excision of cervical precancer
as a predictor of treatment failure: a systematic review and meta-
analysis. Lancet Oncol. 2017;18(12):1665-79.
[17]Bittencourt DD, Zanine RM, Sebastião AM, et al.
Number of fragments, margin status and thermal artifacts of
conized specimens from LLETZ surgery. Sao Paulo Med J.
2012;130(2):92–96. doi:10.1590/S1516-31802012000200004.
[18]Di Donato V, et al. Adjuvant HPV vaccination to prevent
recurrent cervical dysplasia after surgical treatment: a meta-
analysis. Vaccines (Basel). 2023;11(5):947.
(11 摘要 Views, 59 PDF Downloads)
Refbacks
- 当前没有refback。